NCT02213692

Brief Summary

Blood loss during liver resection significantly associates with short term operative outcome. The median blood loss during partial liver resection is 700-1200ml in high-volume centers. Conventional method (crush-clamp) has been a standard technique for liver transection. Technique advances related to liver transection have contributed to reduction in blood loss. Several studies have showed that Harmonic Scalpel in liver resection is safe and easy to use. A nonrandomized study showed use of the Harmonic Scalpel was associated with decreased operative time, blood loss and transfusion requirement, and an increased incidence of postoperative bile leakage. However, no randomized study has compared the difference between liver resection using traditional technology and harmonic Scalpel. The objective of this prospective randomized study is to compare the safety and efficacy of liver resection using the harmonic scalpel device with the "crush-clamp" technique in respect to blood loss, liver transection time, hepatic hilum clamping time, hospital stay and postoperative complications.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

May 30, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 11, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

February 4, 2016

Status Verified

February 1, 2016

Enrollment Period

1.4 years

First QC Date

May 30, 2014

Last Update Submit

February 2, 2016

Conditions

Keywords

Liver ResectionHarmonic ScalpelCrush-clampingA Prospective Randomized Study

Outcome Measures

Primary Outcomes (1)

  • Blood loss

    Amount of blood loss will be assayed during operation.

    intraoperatively operation(an average of 3 hours)

Secondary Outcomes (4)

  • Transection time

    from Mark of the cutting edge to finish disposed of the cutting edge (an average of 1 hour)

  • Hepatic hilar clamping time

    duration of clamping of hepatic hilar (an average of 30 minutes)

  • Hospital stay

    dates from admission to discharge (an average of 8 days)

  • Postoperative complications

    within 7 days after operation

Study Arms (2)

Crush-clamping Method (group A)

Liver parenchymal is crushed by surgeon's fingers or basic surgical clamps to isolate small vessels and biliary radicals, and then divided by suture ligation, electrocautery, or vascular clips.

Harmonic Scalpel Method (group B)

Liver parenchymal transection is transected by harmonic scalpel, and small vessels and biliary radicals (\<3mm) is also divided by harmonic scalpel. Vessels and biliary radicals (≥ 3mm) were divided by suture ligation, electrocautery, or vascular clips.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Genders Eligible for Study: Both Accepts Healthy Volunteers: No

You may qualify if:

  • Age ≥18y, and ≤80y;
  • No history of liver resection and radiotherapy
  • Liver function: Child A with a normal prothrombin time (\<13 seconds) and INR (1.15);
  • Extent of resection ≥2 segment or diameter of tumor (single nodule) ≥ 8cm or cumulative diameter of tumor (multiple nodule) ≥ 8cm; Eligible patients will be stratified by resection in left lobe or right lobe.
  • No tumor thrombosis in main trunk or right and left branch of portal vein or major hepatic vein.

You may not qualify if:

  • Recurrent liver tumor; or simultaneous resection of other organs except gallbladder
  • Prothrombin time \> 13S;
  • Blood platelets count (BPC) \< 60x109
  • Moderate and severe of esophageal varices detected by CT or MRI
  • Diameter of portal vein \> 14mm (color ultrasound)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Hospital of Fudan University

Shanghai, Shanghai Municipality, 200032, China

Location

MeSH Terms

Conditions

Liver Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver Diseases

Study Officials

  • Hui Chuan Sun, Professor

    Fudan University

    STUDY CHAIR
  • Jia Fan, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Jian Zhou, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Shuang Jian Qiu, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Guo Ming Shi, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Qing Hai Ye, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Lu Wang, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Xiao Wu Huang, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Ning Ren, Professor

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Jing Xian Yu, Nurse

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Yang Xu, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Ying Hong Shi, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Xiao Ying Wang, Asso. Prof

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Jian Sun, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Zheng Wang, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Yong Sheng Xiao, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Pei Chen, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Cheng Huang, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR
  • Ying Hao Shen, Asso. Prof.

    Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 30, 2014

First Posted

August 11, 2014

Study Start

May 1, 2014

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

February 4, 2016

Record last verified: 2016-02

Locations